longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Cerus

CERS

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -78.73, below the reasonable range, cheaper than 94.25% of the time in the past 1 years, and the industry ranks 42/45, the industry Median -0.42.

-78.73xP/E
$2.65Stock price
$-0.03Earnings per share
-78.73xP/E
Stock price$2.65Earnings per share$-0.03

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-27.31x
Typical range
-63.78x–-21.18x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
015304560

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
MMEDUSMiniMed
-19.52x146.72%$6.13B
BLCOUSBausch + Lomb
-35.19x94.03%$6.02B
NEOGUSNeogen
-358.83x316.68%$2.83B
ESTAUSEstablishment Labs
-53.10x30.16%$2.07B
XRAYUSDentsply Sirona
-3.48x113.34%$1.90B
KIDSUSOrthopediatrics
-14.34x27.74%$569.72M
CERSUSCerus
-78.73x56.25%$534.04M
SMTIUSSanara Medtech
-10.06x104.59%$322.22M
OSURUSOraSure Tech
-5.00x29.79%$245.53M
RXSTUSRxSight
-4.61x0.68%$216.28M
SKYAUSSkyAI
-0.18x--$73.30M
ZTEKFUSZENTEK LTD
-7.72x--$57.90M
TELAUSTela Bio
-1.36x17.67%$56.12M
XTNTUSXtant Med
-4.03x477.77%$44.89M
NSPRUSInspireMD
-0.68x--$35.68M
RMTIUSRockwell Medical
-6.20x32.67%$32.51M
RVPUSRetractable Tech
-5.98x--$21.53M
CUPRUSCuprina
-3.48x--$12.54M
LUCYUSInnovative Eyewear
-1.06x--$8.18M
AIDXUS20/20 Biolabs
-0.83x44.74%$5.94M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.